Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Partner news

Period

2019
2018
2016
2015
2014
2012
2011
2010

Jan
Feb
Mar
Apr
(-) May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

Cala Health Raises $50 Million Series C Funding

Read full story

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story

Zebra Medical Vision Receives FDA Approval for World's First AI Chest X-ray Triage Product

Read full story

GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing

Read full story

BRIEF-Provention Bio Files For IPO Of Up To $50 Million

Read full story

Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders

Read full story

NeuroVision Announces a $15 Million Series C Financing With a First Close of $11.2 Million

Read full story

Merus Announces First Patient Dosed in Phase 1/2 Trial Evaluating Bispecific Antibody Candidate MCLA-117 in Patients

Read full story

Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to Combat Hepatitis C Virus

Read full story

Inspire Medical Systems Raises $40 Million in Series E Funding

Read full story

Nevro Receives FDA Approval to Initiate Landmark U.S. Randomized Pivotal Trial of Innovative Chronic Pain Treatment

Read full story

Study Results of Novocure's NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer

Read full story

Mitralign Raises $35 Million Series D Financing

Read full story

Novocure Announces Launch of Recurrent Glioblastoma Product Website

Read full story

Celladon Corporation Completes Second Close of Recent Venture Financing

Read full story

Load More

Sidebar

Currently trending

Currently trending

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
The science of prevention
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

Trending

Trending

Change 1 Thing, Change Everything: Improving Contact Lenses

Change 1 Thing, Change Everything: Improving Hip Replacement

Johnson & Johnson Innovation, Change One Thing, Change Everything: AdoRx